Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIME: Methylphenidate Primed iTBS for Apathy in Dementia
NCT07279740Phase 2Recruiting
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Jan 2026
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methylphenidate in apathy, sponsored by Sunnybrook Health Sciences Centre. Started Jan 2026; status: recruiting.
02
Drugs
methylphenidate
03
Conditions
apathy
Beyond the preview
Go deeper on NCT07279740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07279740.